Crispr Therapeutics shares tumble after significant earnings miss
LONDON - Geiger Counter Limited has repurchased 87,303 ordinary shares at an average price of 46.71 pence per share on July 31, according to a company statement released Friday.
The uranium investment company will hold all repurchased shares in treasury. Since its Annual General Meeting on March 5, 2025, Geiger Counter has bought back a total of 17,978,253 ordinary shares.
Following this latest transaction, the company now has 115,542,793 ordinary shares with voting rights in issue, plus 37,131,456 ordinary shares held in treasury.
The share buyback is part of the company’s ongoing repurchase program, which was approved at the March shareholders’ meeting.
Geiger Counter Limited specializes in uranium and uranium-related investments. The company is listed on the London Stock Exchange (LON:LSEG).
The information was disclosed in a regulatory announcement to the London Stock Exchange.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.